DNA ‘Reverse’ Vaccine Reduces Levels of Immune Cells Believed Responsible for Type 1 Diabetes

On November 3, 2013, in Articles, Clinical Trials, News, by RCTherapy

June 26, 2013 – Read Full Article on Science Daily A clinical trial of a vaccine, led by Stanford University School of Medicine researchers and designed to combat type-1 diabetes, has delivered initially promising results, suggesting that it may selectively […]

Alternative Treatments for Diabetes

On March 21, 2013, in Articles, Clinical Trials, News, by RCTherapy

Original Article Source Never need insulin injections again! A peptide synthesized by Israeli researchers provides a radically improved weapon against Type 1 diabetes, stopping it at its source. Israeli drug maker Teva Pharmaceutical Industries and Clal Biotechnology Industries (CBI) have […]

Experimental Therapy Crosses Blood-brain Barrier to Treat Neurological Disease

On February 17, 2013, in Articles, Clinical Trials, by RCTherapy

February 4, 2013 in Medical research Researchers have overcome a major challenge to treating brain diseases by engineering an experimental molecular therapy that crosses the blood-brain barrier to reverse neurological lysosomal storage disease in mice. Posted online in PNAS Early […]

Optimization of scAAVIL-1ra In Vitro and In Vivo to Deliver High Levels of Therapeutic Protein for Treatment of Osteoarthritis

On February 17, 2013, in Articles, Clinical Trials, by RCTherapy

Read Full Report   Abstract Osteoarthritis (OA) affects over 40 million people annually. We evaluated interleukin-1 receptor antagonist (IL-1ra) gene transfer in an equine model based on IL-1ra protein therapy which inhibits inflammation through blocking IL-1. Using the self-complementary adeno-associated […]

Experimental Peptides Prevent Diabetes & Halt Its Progression

On December 17, 2012, in Articles, Clinical Trials, by RCTherapy

News: Just released by the University of South Carolina. By LESLIE H. LANG UNC-CH School of Medicine CHAPEL HILL — Injections of protein fragments prevented the development of type-I diabetes in a strain of mice prone to the disease, according […]

Multiple Myeloma Treatment

On February 8, 2012, in Articles, Clinical Trials, by RCTherapy

Apigenin inhibits proliferation and induces apoptosis through targeting the trinity of CK2, Cdc37 and Hsp90. 2011 BioMed Research – Abstract – Background: Multiple myeloma (MM) is a B-cell malignancy that is largely incurable and is characterized by the accumulation of […]

Clinical Analysis of the Fibroblast Growth Factor

On December 28, 2011, in Articles, Clinical Trials, by RCTherapy

NEUROTROPHIC FACTORS: Published:  Monday, October 24th, 2011 Download the complete Report Here. In this publication we will give you a general overview of Neurotrophic Factors and the Neurophysiological Evaluation we applied. Studies are being made for consistency and power analysis […]

© 2013 Regenerative Cellular Therapy
Terms and Conditions     |     Privacy Policy     |     Sitemap